Addressing unmet needs in the treatment of COPD
The burden of chronic obstructive pulmonary disease (COPD) is considerable, both socially and economically. Central to COPD management is the use of long-acting bronchodilators, which provide patients with optimal bronchodilation and improvements in symptoms. The once-daily, long-acting β2-agonist i...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2014-09-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/23/133/333.full.pdf+html |